Lesson plan
Roche Tower
Roche Tower (German: Roche-Turm), also known as Building 1 (German: Bau 1), is an office skyscraper in the Swiss city of Basel. Designed by Herzog & de Meuron for the pharmaceutical company Hoffmann-La Roche, it stands 178 metres (584 ft) tall with 41 floors. At the time of its opening, it was the tallest building in Switzerland, surpassing the Prime Tower (126 meters) in Zürich by 52 metres. The building has a total floor space of and cost CHF 550 million to construct. It houses around 2,000 employees. In 2020, Roche Tower was overtaken in height by the adjacent 205-metre Building 2, also developed by Roche.
Article summary
Roche Tower (German: Roche-Turm), also known as Building 1 (German: Bau 1), is an office skyscraper in the Swiss city of Basel. Designed by Herzog & de Meuron for the pharmaceutical company Hoffmann-La Roche, it stands 178 metres (584 ft) tall with 41 floors. At the time of its opening, it was the tallest building in Switzerland, surpassing the Prime Tower (126 meters) in Zürich by 52 metres. The building has a total floor space of and cost CHF 550 million to construct. It houses around 2,000 employees. In 2020, Roche Tower was overtaken in height by the adjacent 205-metre Building 2, also developed by Roche.
Key claims
- employees: 2,000 employees — source: Wikipedia, revision 1364624253, retrieved 2026-10-20 · confidence 0.95
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- The record states that the employees is "2,000 employees". What evidence would count against this claim?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
- Wikipedia, “Roche Tower”, revision 1364624253, retrieved 2026-10-20 https://en.wikipedia.org/w/index.php?oldid=1364624253
Key claims and bibliography are generated from the same tracked claims and sources as the article page.